Drug intelligence / Profile preview

iodophen I-123

Development stage: Unknown
Lead developer: V.G. Khlopin Radium Institute
Modality: Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration: Intravenous

Overview

Iodophen I-123 is a diagnostic radiopharmaceutical developed by the Khlopin Radium Institute. It consists of a fatty acid analog labeled with the radioisotope iodine-123, specifically designed for Single Photon Emission Computed Tomography (SPECT) imaging of the heart. The agent acts as a metabolic tracer, allowing clinicians to visualize and assess myocardial fatty acid metabolism. It is primarily used to evaluate myocardial viability and diagnose conditions such as ischemic heart disease, acute myocardial infarction, and coronary small vessel disease. By monitoring the uptake and distribution of the tracer, clinicians can also assess the effectiveness of ongoing therapies for ischemic heart disease.

Brand names: IodophenЙодофен
Other names: 123I IodophenIodophen (123I)

Targets

CD36 (CD36 antigen)

Beyond the preview

Go deeper on iodophen I-123.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodophen I-123.

Explore the full profile